Edition:
United Kingdom

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

1.87USD
7:28pm GMT
Change (% chg)

$-0.64 (-25.70%)
Prev Close
$2.51
Open
$1.94
Day's High
$1.97
Day's Low
$1.84
Volume
1,473,772
Avg. Vol
188,996
52-wk High
$10.05
52-wk Low
$1.84

Latest Key Developments (Source: Significant Developments)

Aratana Therapeutics Granted Conditional License For A Canine Osteosarcoma Therapeutic
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Advaxis Inc ::ARATANA THERAPEUTICS GRANTED CONDITIONAL LICENSE FOR A CANINE OSTEOSARCOMA THERAPEUTIC.ARATANA THERAPEUTICS-U.S. DEPARTMENT OF AGRICULTURE CENTER FOR VETERINARY BIOLOGICS GRANTED CONDITIONAL LICENSE​ FOR CANINE OSTEOSARCOMA VACCINE,AT-014.  Full Article

Amgen reports 8.9 pct passive stake in Advaxis as of Aug 1
Tuesday, 2 Aug 2016 

Amgen Inc Reports 8.9 Pct Passive Stake In Advaxis Inc As Of August 1 :Sec filing.  Full Article

Advaxis files for common stock offering
Tuesday, 2 Aug 2016 

Advaxis Inc :Files for common stock offering of up to 3.05 million shares - SEC filing.  Full Article

Advaxis Inc says FDA grants advaxis fast track designation for ADXS-HER2
Thursday, 28 Apr 2016 

Advaxis Inc:Says FDA has granted fast track designation for company's immunotherapy product candidate ADXS-HER2 for patients with newly-diagnosed, non-metastatic, surgically-resectable osteosarcoma.  Full Article

BRIEF-Advaxis Prices $20.0 Mln Public Offering Of Common Stock

* ADVAXIS PRICES $20.0 MILLION PUBLIC OFFERING OF COMMON STOCK